Generation of T lineage cells from human embryonic stem cells in a feeder free system

Stem Cells

Volumn 27, Issue 1, 2009, Pages 100-107

  Galić, Zoran ^a   Kitchen, Scott G ^a   Subramanian, Aparna ^a   Bristol, Greg ^a   Marsden, Matthew D ^a   Balamurugan, Arumugam ^a   Kacena, Amelia ^a   Yang, Otto ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Embryoid bodies; Gene therapy; Hematopoiesis; Human embryonic stem cells; T cell development

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; COCULTURE; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PHENOTYPE; PRE T LYMPHOCYTE; T LYMPHOCYTE; TRANSGENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; GREEN FLUORESCENT PROTEINS; HEMATOPOIESIS; HUMANS; KINETICS; MICE; PHENOTYPE; T-LYMPHOCYTES;

MURINAE; MUS;

EID: 59849092903     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0813     Document Type: Article

References (46)

1. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008;132:661-680.
2. Kaufman DS, Hanson ET, Lewis RL et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2001;98:10716-10721.
3. Chadwick K, Wang L, Li L et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003;102:906-915.
4. Vodyanik MA, Bork JA, Thomson JA et al. Human embryonic stem cell-derived CD34+ cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005;105:617-626.
5. Ng ES, Davis RP, Azzola L et al. Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 2005;106:1601-1603.
6. Zambidis ET, Peault B, Park TS et al. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005;106:860-870.
7. Kennedy M, D'Souza SL, Lynch-Kattman M et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 2007;109:2679-2687.
8. Pick M, Azzola L, Mossman A et al. Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. STEM CELLS 2007;25:2206-2214.
9. Galic Z, Kitchen SG, Kacena A et al. T lineage differentiation from human embryonic stem cells. Proc Natl Acad Sci U S A 2006;103:11742-11747.
10. Trounson A. The production and directed differentiation of human embryonic stem cells. Endocr Rev 2006;27:208-219.
11. Gropp M, Itsykson P, Singer O et al. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 2003;7:281-287.
12. Qin XF, An DS, Chen IS et al. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 2003;100:183-188.
13. Aldrovandi GM, Feuer G, Gao L et al. The SCID-hu mouse as a model for HIV-1 infection. Nature 1993;363:732-736.
14. Killian MS, Sabado RL, Kilpatrick S et al. Clonal breadth of the HIV-1-specific T-cell receptor repertoire in vivo as determined by subtractive analysis. Aids 2005;19:887-896.
15. Currier JR, Deulofeut H, Barron KS et al. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum Immunol 1996;48:39-51.
16. Plotkin J, Prockop SE, Lepique A et al. Critical role for CXCR4 signaling in progenitor localization and T cell differentiation in the postnatal thymus. J Immunol 2003;171:4521-4527.
17. Namikawa R, Weilbaecher KN, Kaneshima H et al. Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 1990;172:1055-1063.
18. McCune JM, Namikawa R, Kaneshima H et al. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-1639.
19. Akkina RK, Rosenblatt JD, Campbell AG et al. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 1994;84:1393-1398.
20. Amado RG, Symonds G, Jamieson BD et al. Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cells. Hum Gene Ther 1998;9:173-183.
21. Bonyhadi ML, Moss K, Voytovich A et al. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J Virol 1997;71:4707-4716.
22. Blom B, Spits H. Development of human lymphoid cells. Annu Rev Immunol 2006;24:287-320.
23. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-181.
24. Jamieson BD, Douek DC, Killian S et al. Generation of functional thymocytes in the human adult. Immunity 1999;10:569-575.
25. Martin CH, Woll PS, Ni Z et al. Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood 2008;112:2730-2737.
26. Cavazzana-Calvo M, Lagresle C, Hacein-Bey-Abina S et al. Gene therapy for severe combined immunodeficiency. Annu Rev Med 2005;56:585-602.
27. Kershaw MH, Teng MW, Smyth MJ et al. Supernatural T cells: Genetic modification of T cells for cancer therapy. Nat Rev Immunol 2005;5:928-940.
28. Amado RG, Mitsuyasu RT, Rosenblatt JD et al. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther 2004;15:251-262.
29. Morgan RA, Walker R, Carter CS et al. Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals. Hum Gene Ther 2005;16:1065-1074.
30. Macpherson JL, Boyd MP, Arndt AJ et al. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients. J Gene Med 2005;7:552-564.
31. Morgan RA, Dudley ME, Wunderlich JR et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006;314:126-129.
32. Cohen J. Building an HIV-proof immune system. Science 2007;317:612-614.
33. Hoffman LM, Carpenter MK. Characterization and culture of human embryonic stem cells. Nat Biotechnol 2005;23:699-708.
34. Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol 2003;21:319-321.
35. Urbach A, Schuldiner M, Benvenisty N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. STEM CELLS 2004;22:635-641.
36. Costa M, Dottori M, Sourris K et al. A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc 2007;2:792-796.
37. Davis RP, Ng ES, Costa M et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 2008;111:1876-1884.
38. Irion S, Luche H, Gadue P et al. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol 2007;25:1477-1482.
39. Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer 2003;3:477-488.
40. Lei T, Jacob S, Ajil-Zaraa I et al. Xeno-free derivation and culture of human embryonic stem cells: Current status, problems and challenges. Cell Res 2007;17:682-688.
41. King JA, Miller WM. Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol 2007;11:394-398.
42. Kurosawa H. Methods for inducing embryoid body formation: In vitro differentiation system of embryonic stem cells. J Biosci Bioeng 2007;103:389-398.
43. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
44. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
45. Lowry WE, Richter L, Yachechko R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008;105:2883-2888.
46. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.